study question: Does a defect in the human sperm-located protein prostate and testis expressed 1 (PATE1) exist in both aged men and young asthenozoospermia patients?
Introduction
Male infertility is becoming a serious worldwide problem in human society. A total of 15% of couples suffered from fertility problems, of which 50% were related to male factors (De Kretser and Baker, 1999; Sabanegh and Agarwal, 2012) . Sperm quality was the final decisive factor for male fertility (Franken and Oehninger, 2012) . A decline in sperm quality, which may occur under both pathological conditions and natural aging events, is therefore an important reason for the occurrence of male infertility.
Asthenozoospermia, associated with characteristic of poor sperm quality (especially of declined sperm motility), is the common pathological cause of male infertility (especially in young men). To investigate its underlying molecular basis, proteomic analysis of spermatozoa from the asthenozoospermia patients has been reported (Amaral et al., 2014a,b) . Some related proteins and enriched pathways were identified (Zhao et al., 2007; Martinez-Heredia et al., 2008; Chan et al., 2009; Siva et al., 2010; Parte et al., 2012; Shen et al., 2013; Amaral et al., 2014a,b) . However, the molecular mechanism of asthenozoospermia has not yet been fully explored.
Insufficient motility was also reported to be one of the characteristics of sperm from the aging men (Rolf et al., 1996) . Whether there is a similar molecular basis of the poor sperm quality between the pathological asthenozoospermia and the physiological aging process, at this point, deserves to be further investigated. It was well known that testicular functions declined with aging (Perheentupa and Huhtaniemi, 2009) , while sperm quality was mainly affected by the functions of testis. Thus the aging process was potentially responsible for sperm quality. It was reported that there were negative influences of advancing age on semen volume, sperm motility and morphology (Kidd et al., 2001; Kühnert and Nieschlag, 2004; Sloter et al., 2006; Winkle et al., 2009; Zhu et al., 2011) . However, age-related sperm proteomic analysis has still not been reported, and the molecular basis of aging on sperm quality was unclear.
In this study, age-related sperm proteins were analyzed by comparative sperm proteomic analysis from young adults and a group of aged men using two-dimensional gel electrophoresis (2DE) separation coupling with matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) identification. These altered proteins may also in turn reflect the age-related functions of testis and epididymis. Among them, prostate and testis expressed 1 (PATE1) was supposed to be promisingly related to reproduction functions. Whether its change on sperm reflected the functions of testis and epididymis, was monitored by parallel morphological, immune-histochemical and immuno-cytochemical studies. Its roles in age-related sperm functions were examined by immunofluorescence quantitative analysis of ejaculated spermatozoa from young adults and aged men. Semen parameters of sperm count (an index of testicular function) and sperm motility (an index of epididymal function) were also used to evaluate the correlation of sperm quantification and sperm function. The research should be thus useful for male infertility research, regulation of reproduction and reproduction health care for the aged man.
Materials and Methods

Sample preparation
The tissue samples including testes and epididymides were prepared for morphological analysis, western blot and immunohistochemistry. The testes and epididymides were obtained from five young fathers (27 -33 years old), who had died in car accidents and had no history of pathology that could affect reproductive functions and had previously indicated a willingness to donate their bodies for medical research. Donation of organs for medical research was approved by their immediate family members. The aged samples of testes and epididymides were collected from five elderly fathers (78-82 years old), who were prostatic cancer patients with no anti-androgen treatment before castration and provided written informed consent. All procedures were approved by the Ethics Committee of Yantai Yu Huang Ding Hospital. The organs from one side were processed for protein extraction and the other for morphology analysis. Human testicular quality was evaluated by the modified Johnsen score described by Bergmann and Kliesch (1998) on Bouin-fixed paraffin-embedded organs divided into four blocks, in which 50 tubule cross sections were assessed for the most advanced germ cells present in them. The collection of sperm-free epididymal luminal fluid and the preparation of epididymal tissue without the luminal contents were as previously described (Li et al., 2010 (Li et al., , 2011 . The proteins were extracted from individual tissues for western blotting.
Semen samples were collected from three groups including 60 healthy young adults (aged 28-32 years), 60 old men (aged 68-72 years) and 110 asthenozoospermic men (aged 25-40 years, progressive motility ,32%). Semen was obtained by masturbation after 7 days of sexual abstinence. Seven days of sexual abstinence can increase the number of sperm cells, but has no effect on sperm morphology, motility and vitality. Comparative sperm proteome was performed between pooled sperm samples from 60 young adults and 60 aged men. Spermatozoa from three groups were used for immunofluorescence quantitative experiments individually. Collection and procession of semen samples were according to the World Health Organization Laboratory Manual for the Examination and Processing of Human Semen (5th edition, 2010). The donations were authorized by the donors, who gave written informed consent, in accordance with the regulations and with permission of the Ethics Committee of Yantai Yu Huang Ding Hospital.
Protein extraction
Sperm samples from 60 young adults and 60 aged men were pooled for protein extraction. As previous reports (Martínez-Heredia et al., 2006) , through centrifugation at 800g for 20 min at 48C in a 50% step Percoll gradient in culture media, the seminal plasma and other potential contaminating cells present in semen can be removed. Fifty percent Percoll was used to produce the representative 2DE gels of the average spermatozoon present in each sperm samples, rather than a sperm subpopulation. In liquid nitrogen, sperm pellets were ground to powder, and dissolved in lysis solution (7 M urea, 2 M thiourea, 4% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate, 65 mM Dithiothreitol, protease inhibitor cocktail) for 2 h and centrifuged at 40 000g for 1 h at 48C. The supernatant was precipitated using three volumes of ice-cold acetone, stored for 1 h at 2208C. Then the sample was thawed and centrifuged at 20 000g for 1 h at 48C. The supernatant was discarded, and the precipitates were washed using pre-cooled acetone, dissolved in the above lysis solution. After the protein concentration was determined (Gotham et al., 1988) , the protein sample was stored at 2808C for use.
2DE and mass spectrometric analysis 2DE was performed as our previously described method (Li et al., 2010 (Li et al., , 2011 . Pooled samples of young adult group and that of aged group were simultaneously isoelectric focused and electrophoresed with same conditions every time. Each group was repeated in triplicate. Non-linear pH 3 -10 immobilized pH gradient strips (18 cm) were used for one-dimensional isoelectric focusing. Then strips were equilibrated with DTT for reduction and iodoacetamide for carboxy methylation. The equilibrated strips were run on 12.5% (w/v) sodium dodecyl sulfate (SDS) 2DE gels at 30 mA per gel and stained with Coomassie Brilliant Blue R-350 (Amersham Biosciences, Piscataway, NJ, USA). 2DE was performed in triplicate to ensure the spot patterns, and then scanned with a Z320 scanner (Founder, Beijing, China) . The spot intensities of each protein in each gel were analyzed by Imagemaster 2D Platinum 6.0 (GE healthcare, Piscataway, NJ, USA) software. Quantitative analysis was performed by Student's t-test (P , 0.05, mean ratio .1.5) between the gels from samples of young adults and aged men. To improve the success of identification by MS, all selected spots from six gels were excised and identified individually. Differential protein spots were excised and destained with 25 mM NH 4 HCO 3 /50% (v/v) acrylonitrile, dried, and digested by 0.01 mg trypsin in 0.01 ml 25 mM NH 4 HCO 3 for 12 h at 378C. Digestion buffer was transferred to a new fresh tube, and then the gel plugs was covered with 50 ml of 1% trifluoro acetic acid (v/v) in 50% (v/v) acetonitrile, and then sonicated for 30 min. This buffer was extracted and combined with the digestion buffer. The combined solution was then freezedried (Labconco, Kansas City, MO, USA). The resultant peptides were re-dissolved in 10 ml of 0.5% (v/v) trifluoroacetic acid in Milli-Q water. A Voyager DE-STR biospectrometry work station (Applied Biosystems/MDS SCIEX, Foster City, CA, USA) was used to analyze the peptides.
The MALDI-TOF MS was operated as in our previous protocol (20). Briefly, an acceleration voltage of 20 kV, a grid voltage setting of 72%, and a 120 ns delay was set in the delayed extraction/reflector mode with. Positively charged ions signals were collected in the above mode. The ProteomMass peptide and protein MALDI-MS calibration kit (Sigma, St. Louis, MO, USA) were used for external calibration. Each mass spectrum was the sum of 200 laser shots from 25 different positions in each spot. Mass spectra were performed by Data explorer 4.0 (Applied Biosystems/MDS SCIEX, Foster City, CA, USA). The parameters were set as m/z range 800-3500, resolution .10 000, S/N threshold .10.0, and internal calibration by trypsin auto digestion peaks (trypsin_ [108 -115] Trypsin was set as the enzyme, one missed cleavage site was allowed, cysteine carbamidomethyl was set as a fixed modification and oxidized methionine was set as a variable modification. Peptide mass tolerance was +0.3 Da. If the mascot score was .60 and at least four peptides were matched for peptide mass fingerprinting (significance level, P , 0.05), protein hits were identified. If more than one protein was identified in a spot, the single protein member with the highest score (top rank) was chosen from the multi-protein family.
Bioinformatics
All proteins were functionally grouped into several categories according to Gene Ontology (http://www.geneontology.org/) and literature annotation in PubMed.
Western blot
Protein samples from human testis, epididymis, epididymal fluids and ejaculated sperm were separated by SDS polyacrylamide gel electrophoresis, respectively. Then they were transferred to polyvinylidenedifluoride membranes, blocked with 2% (w/v) skimmed milk for 1 h, and co-incubated for 1 h with the primary antibody of PATE1 (ab173522, Abcam, Cambridge, UK) at room temperature with gentle agitation. The membranes were washed with 0.5% (v/v) Tween-20 in Tris-buffered saline for three times, and then incubated with horse-radish peroxidase-conjugated anti-IgG for 1 h at room temperature. The immune-reactive complexes were detected with Amersham ECL kit (Amersham Life Science, Cleveland, OH, USA). After ECL detection, the membrane was washed with Tris-buffered saline with Tween-20 (TBST) three times and then incubated in stripping buffer (62.5 mM Tris pH 6.8, 2% SDS, 100 mM 2-Mercaptoethanol) in a heat-sealed plastic bag for 45 min at 508C with occasional mixing. The stripped membrane was washed three times with TBST, and then re-blocked and co-incubated with control antibody of beta Actin (ab8227, Abcam, Cambridge, UK). The image was analyzed by commercial image analysis software (Gene Tools, version 4.02; Syngene, Cambridge, UK). The integrated optical density (IOD) of positive immune-staining was calculated, and the IOD ratio of target protein to ACTIN was used to express the results of western blot.
Immunohistochemistry
Testicular and epididymal tissue blocks were fixed in Bouin's solution (Sigma, St. Louis, MO, USA) for 10 h, and then were embedded by paraffin according to the conventional methods. Four micrometer thickness sections were de-waxed, and antigen retrieval was treated in a micro wave oven for 15 min. Endogenous peroxidases of sections were inhibited by incubation with 3% (v/v) H 2 O 2 for 1 h. Then 3% (w/v) bovine serum albumin (BSA) in Tris-buffered saline (TBS) was used to block non-specific binding of antibodies at room temperature. Sections were then incubated with primary antibody of PATE1 (ab173522, Abcam, Cambridge, UK) (diluted 1:100 in blocking solution) overnight at 48C. After the sections were washed with TBS for three times, sections were incubated with horse-radish peroxidaseconjugated anti-rabbit IgG (Zhong-Shan Biotechnology, Beijing, China) at a final dilution of 1:400 for 1 h at 378C. A DAB kit (Zhong-Shan Biotechnology, Beijing, China) was used to visualize the peroxidase activity at binding sites. Hematoxylin was used to counterstain the sections. Then the sections were dehydrated and mounted for bright-field microscopy (DM LB2, Leica, Nussloch, Germany). Pre-immune rabbit IgG was used as a negative control. The positive immunostaining was used to analyze the quantitative results. Briefly, images of immunostained sections were analyzed with commercial image analysis software (Image-Pro Plus 6.0; Media Cybernetics, Silver Spring, MD, USA). The unequal illumination was processed by shading correction, and a reference slide was used to correct the measurement system. Ten fields of each section were scored for each tissue. After the immunostaining images were converted to grayscale, a linear combination between the average gray signal intensity and the relative area of positive staining cells was defined as the IOD.
Immunofluorescence quantitative assessment of protein expression in spermatozoa
Semen samples from 60 young adults, 60 aged men and 110 asthenozoospermia patients were analyzed individually by immunofluorescence. After PATE1 defect on sperm of asthenozoospermia and aged men liquefaction, 1 ml semen sample was diluted to 10 ml with phosphatebuffered saline (PBS) mixed and centrifuged at 800g for 10 min. The supernatant was discarded and the sperm pellet was resuspended in PBS by gentle pipetting. This was centrifuged at 500g for 10 min and the washing procedure repeated three times with PBS. The washed spermatozoa were smeared on slides pre-coated with 1% (w/v) gelatin. The air-dried slides were fixed with 2208C methanol for 10 min, blocked for 1 h at room temperature with 3% (w/v) bovine serum albumin (BSA) in PBS and incubated at 378C for 1 h with primary antibody of PATE1 (ab173522, Abcam, Cambridge, UK) diluted 1:50 in PBS containing 3% (w/v) BSA. After three washes with PBS, the corresponding secondary antibody was applied (fluorescein isothiocyanate labeled anti-rabbit IgG, 1:100 in PBS containing 3% (w/v) BSA) and incubated at room temperature for 1 h; rabbit IgG was used as a negative control. Samples were subsequently washed in PBS and deionized water. Propidium iodide (0.01 mg/ml, Invitrogen, Carlsbad, CA, USA) counterstaining visualized the nuclei and sections were mounted in 80% (v/v) glycerol and examined with a confocal laser scanning microscope (LSM-510 META; Carl Zeiss, Jena, Germany). Quantitative assessment of protein expression in spermatozoa was achieved by a Zeiss LSM 510 laser confocal microscope (LSM, Carl Zeiss Microimaging, Thornwood, NY, USA). Slides were systematically examined at 400× magnification according to the World Health Organization manual 2010. Inspection was performed in sequence until a total of 200 spermatozoa had been assessed. By using Zeiss LSM 510 Meta software (LSM 5 version 3.2, Carl Zeiss Microimaging, Thornwood, NY, USA), the fluorescence intensity value per stained cell was calculated automatically by subtracting the background fluorescence intensity, which was determined by scanning a sperm-free area.
Sperm motility analysis
After the semen was liquefied at 378C for 30 min, swim-up of spermatozoa was performed in M199 buffer (Sigma, St. Louis, MO, USA). After the swim-up, sperm were centrifuged at 500g for 5 min, Biggers-WhittenWhittingham buffer (35 mg/ml BSA and 25 mM bicarbonate) was used to wash the sperm pellet twice and the sperm concentration was adjusted to 3 × 10 7 /ml. An irrelevant IgG (0.02 mg/ml; Sigma, St. Louis, MO, USA) was added to the control tubes, and 0.02 mg/ml affinity-purified antibody against PATE1 was added to the test samples. Both tubes were incubated in 5%(v/v) CO 2 for 1 h at 378C. Then the samples were placed in 20-mm deep chambers (2X-CEL, Hamilton Thorne Research, Beverly, MA, USA) and the motility parameters were measured and recorded at 378C by computer-aided sperm analyzer (HTM-IVOS, Version 12.3, Hamilton Thorne Research, Beverly, MA, USA).
Zona-free hamster oocyte penetration test
The sperm penetration assay was performed according to the WHO Laboratory Manual for the Examination and Processing of Human Semen (5th edition, 2010). Briefly, after the semen was liquefied at 378C for 30 min, highly motile spermatozoa were pooled by the 80% density-gradient centrifugation. Finally the collected spermatozoa were diluted to 5 × 10 6 per ml in BWW. 1.5 mmol/l of Calcium ionophore A23187 (Sigma, St Louis, MO, USA) was added to the spermatozoa solution for 3 h at 378C to get sperm capacitation. Antibody against PATE1 was co-incubated in 5% (v/v) CO 2 for 1 h at 378C at the concentration of 5 mg/ml and 20 mg/ml. Zona-free hamster oocytes from 10 hamsters were obtained according to the WHO criteria, and co-incubation with spermatozoa was performed. Sperm samples were collected from 10 normal young adults, and each sample with 100 ml sperm cells was co-incubated with about five freshly prepared zona-free eggs in the control, 5 mg/ml and 20 mg/ml of PATE1 antibody experiments. Sperm without antibody incubation was used as control. The number of sperm penetrations per oocyte (penetration index, PI) was recorded.
Statistical analysis
Data are reported as mean + SD. Two group means were compared using the Student's t-test, and more than two group means were analyzed by one-way analysis of variance (ANOVA), where P , 0.05 was considered statistically significant. A commercial software package (SPSS 18.0; SPSS, Chicago, IL, USA) was used to perform the correlation analysis. A value of P , 0.05 was considered to be statistically significant.
Results
Characteristic of young adult and aged human testis, epididymis and ejaculated sperm
As revealed by histology, the percentage of tubules with elongating and elongated spermatids in the aged testes (89.3 + 0.7) was significantly lower (Mann-Whitney rank sum test, P , 0.05) than that of the young adult men (97.2 + 0.5) (Supplementary data, Fig. S1 ). Nevertheless, there was no significant difference in the mean modified Johnsen scores which revealed full spermatogenesis in the five young adult men (median 10), and the five aged men (median 9) (Supplementary data, Table SI ). No significant differences were shown between young adult and aged epididymides, except for slightly decreasing height of cauda epithelium and increasing extracellular matrix in aged epididymides (Supplementary data, Fig. S1 ). Comparative analysis of semen parameters between 30 and 70 years old men showed that the decreased total sperm count and decreased progressive sperm motility were observed in 70 years old men (Supplementary data, Fig. S2 ).
Identification of differential sperm proteins between young adult and aged men
Differential proteome analysis of human spermatozoa in young adult and aged men showed that 22 spots have significant differential density values (P , 0.05, mean ratio .1.5), and were identified by mass spectrometry (Supplementary data, Fig. S3 ). As shown in Supplementary data, Fig. S4A , we found that 13 proteins were expressed at higher levels in the young adults group. However, nine proteins were highly expressed in aged men. The details of identified proteins were tabulated in Table I . All the proteins were generally grouped into six broad functional clusters. The majority were related to structural, chaperone and enzyme activity functions, followed by signal transduction, reproduction and transport functions. Interestingly, PATE1 was reported to be closely related to reproduction, and the functional association of PATE1 with sperm was further validated and studied.
Western blot analysis of PATE1 expression in young adult and aged human testes and epididymides
Western blot showed that PATE1 was highly expressed in samples from young adult and aged men, including human testis, epididymis, epididymal fluids and ejaculated sperm. As shown in Fig. 1 , a higher level of PATE1 protein was detected in the testis and epididymal fluid in the young adult group. A regionalized expression pattern of PATE1 was observed in epididymis, with higher levels in the corpus epididymis.
However, PATE1 level was significantly lower in epididymis (caput, corpus and cauda), ejaculated sperm and epididymal fluid in aged men, compared with the corresponding samples from young adults (Fig. 1) .
Cellular distribution of PATE1 in the human testis and epididymis Figure 2 showed the cellular localization of PATE1 protein in the human testis and epididymis of the young adult and aged men. In testis, PATE1 was expressed in leydig cells and germ cells (spermatogonia, spermatocytes, spermatids). In the epididymis, PATE1 was mainly expressed in the principle cells. We found that PATE1 was highly expressed in testis, and moderately expressed in corpus and caudal epididymis. Compared with young adult group, PATE1 was lower in the testis and epididymis of aged groups. In particular, a significant decline in PATE1 protein was found in the epididymis with ageing.
Immunofluorescence quantitative analysis of PATE1 in ejaculated spermatozoa of young adults, aged men and young asthenospermia patients
Immunofluorescence analysis indicated that PATE1 was located on the sperm equatorial segment. Quantification of protein localization was made by confocal scanning microscopy and showed that the percentage of sperm with positive staining for PATE1 was decreased and fluorescence intensity in asthenospermia patients and aged men than that in normal young adults (Fig. 3) . Figure 1 Western blot analysis of protein prostate and testis expressed 1 (PATE1) in the human testis, epididymis, sperm and epididymal fluid from young adults and aged men. Tissue samples were obtained from young adults (27-33 years old, n ¼ 5) and aged men (78-82 years old, n ¼ 5). Spermatozoa were collected from 60 young adults (28-32 years old) and 60 aged men (68-72 years old). The control antibody was raised against beta Actin. IOD, integrated optical density. Data were analyzed by Student's t-test, P , 0.05. Figure 2 Immunohistochemical localization of PATE1 in sections of the young adult and aged human testis and epididymis. Five samples from young adults (27-33 years old) and from five aged men (78-82 years old) were analyzed immunohistochemically. Pre-immune rabbit IgG was used as a negative control. Data were compared by one-way analysis of variance (ANOVA). *P , 0.05. Each bar represents 40 mm.
Association of PATE1 protein with sperm functions
There was a significant correlation between quantification of PATE1 on ejaculated spermatozoa and progressive sperm motility. Correlation coefficients of staining percentage and progressive sperm motility were between 0.453 and 0.536, with high coefficients in sperm of asthenozoospermia patients. Higher coefficient (0.532) with intensity was in spermatozoa of aged men. Correlations with total sperm count were not significant (Table II) .
The antibody against PATE1 significantly decreased the rectilinear velocity and beat cross frequency of capacitated spermatozoa compared with control values obtained in the presence of an equal concentration of irrelevant IgG (Supplementary data, Table SII ).
The sperm were incubated with various dilutions of antibody against PATE1. The average numbers of sperm penetrations per oolemma (PI) were measured. The PI decreased significantly (P , 0.05) following incubation of sperm with antibody (Ab) against PATE1 (without Ab, 6.9 + 2.7; Ab 5 mg/ml, 5.2 + 3.1; Ab 20 mg/ml, 3.3 + 1.9) (Supplementary data, Fig. S5 ). PATE1 defect on sperm of asthenozoospermia and aged men
Discussion
Spermatozoa from the aging men and young asthenozoospermia patients have the common characteristic of aberrant motility, thus whether they have a similar molecular basis responsible for poor sperm quality deserved to be studied. The present study firstly identified differentially expressed sperm proteins between critically selected samples from aged and young adult men. Compared with semen parameters of 30-year-old men, a dramatic decline in total sperm count and progressive sperm motility in 70-year-old men was observed. The identified differential proteins were mainly related to structure, chaperone and enzyme activity, followed by signal transduction, reproduction and transport functions, which were corresponding to the pathways of signaling transduction, cytoskeleton reorganization, closely related to sperm motility. Six proteins (27.2%) of the 22 identified differential proteins have been reported to be differentially expressed in the sperm from young asthenozoospermia patients (Zhao et al., 2007; Martinez-Heredia et al., 2008; Chan et al., 2009; Siva et al., 2010; Parte et al., 2012; Shen et al., 2013; Amaral et al., 2014a,b) . It was suggested that some similar molecular basis may link the poor sperm quality in aged men and young asthenozoospermia patients.
Of these proteins, PATE1 was the promising reproductive protein. It was reported to be expressed mainly in the male genital tract, and involved in sperm-egg fusion and penetration (Bera et al., 2002; SolerGarcía et al., 2005; Fu-Jun and Xiao-Fang, 2012; Margalit et al., 2012) . Our previous study identified that PATE1 was an epididymal secreted sperm-located protein, which was involved in the potential sperm function of motility (Li et al., 2010; Fu-Jun and Xiao-Fang, 2012) . However, the expression of PATE1 in human testis or epididymis, and its functions within sperm were not well characterized. In this study, an age-related expression of PATE1 protein in human testis and epididymis, and the functional relationships of PATE1 with sperm quality were investigated systematically.
Analysis of the overall distribution of PATE1 protein expression by western blot showed that it was expressed in human testis, epididymis, epididymal fluid and ejaculated sperm, as in a previous report of its mRNA expression (Margalit et al., 2012) . Immunochemistry analysis showed that PATE1 was mainly expressed in testis, corpus epididymis and epididymal fluid, leading to the hypothesis that PATE1 may be involved in sperm maturation, in addition to its potential role in spermatogenesis. Further comparison of its corresponding expression between young adult and aged men showed that the age-related decline in expression of PATE1 was mainly observed in epididymis, epididymal fluid and ejaculated spermatozoa. We hypothesized that the decline in expression in ejaculated sperm may be related to altered sperm functions, and the resulting decline may be due to an altered expression of upstream origin, especially in epididymis or sperm milieu. We analyzed the age-related ejaculated sperm quality, and found the sperm motility and sperm numbers were significantly reduced in aged men. Generally, sperm total numbers reflect the testicular functions, and sperm motility mainly reflects epididymal functions. Furthermore, we analyzed the significant relationship between localization of PATE1 (intensity and number of sperm with positive staining) and sperm parameters (motility and total number). The result showed that the localization of PATE1 in sperm was closely related to sperm motility. These results indicate the expression of PATE1 in maturate sperm is mainly regulated by epididymal factors. Thus we further analyzed the cellular localization of PATE1 in human testis and epididymis. The results showed that the expression of PATE1 was higher in the testis and corpus epididymis, and lower in the corresponding tissues from aged men, which was consistent with the western blot results. Meanwhile, no significant difference of spermatogenesis in the young adults and aged men was observed by the modified Johnsen score assessment. So the combined results led to the conclusion that altered PATE1 expression in maturate sperm may be mainly regulated by epididymal factors, especially the epididymal fluid.
Levels of PATE1 protein on maturate sperm may be related to sperm function, so we quantitatively compared its expression on ejaculated sperm from young adults, aged men and young asthenozoospermia patients. The results showed a decline in intensity and percentage of PATE1-positive cells in the ejaculated sperm from aged men and asthenozoospermia patients. PATE1 may therefore be used as a potential biomarker for assessment of sperm quality. To investigate the roles of PATE1 in sperm function, we performed an antibody blocking experiment and showed that PATE1 antibody may inhibit sperm motility and sperm-egg penetration. Thus PATE1 may serve as one important candidate protein in regulation of sperm function. It was also a key protein involved in the process of declining sperm quality. PATE1 was mainly regulated by the epididymal epididymal fluid, and could potentially be used as a candidate epididymal contraceptive target.
In conclusion, this study first defined the age-related differentially expressed sperm proteins in men. The key sperm protein PATE1, mainly regulated by epididymal factors, was further studied and validated. Our data indicate there is a common molecular basis for the process of the decline in sperm quality in young asthenozoospermia patients and aged men, while the physiological and pathological changes occur in different time schedules. Taken together, the results provided new insights Linear regression correlation coefficients from confocal scanning microscopic evaluation. Statistical significance of coefficients ***P , 0.0001, **P , 0.001, *P , 0.01, NS, Non-significant.
into our understanding of sperm function regulation, and may greatly contribute to the molecular evaluation of sperm quality and to the diagnosis and treatment of asthenozoospermia.
